Hassan Maishera
The Injective team announced via X on Thursday the launch of AINJ, the Injective Staking Exchange Traded Product (ETP), launched by 21Shares. The product offers exposure to $INJ via major traditional finance exchange venues and brokerages while also capturing staking rewards.
AINJ is provided by 21Shares, a primary issuer of crypto ETPs. 21Shares is also one of the leading organizations to spearhead efforts for the Bitcoin ETF, with over $3 billion of assets under management for the $BTC ETF alone.
AINJ captures INJ staking rewards and compounds them, replicating on-chain staking participation in the world of traditional finance. AINJ is supported by major financial institutions such as Interactive Brokers, Saxo Bank, Swissquote, eToro, and more.
Injective is an open, interoperable layer-one blockchain for building powerful DeFi applications. Injective uniquely provides plug-and-play financial infrastructure primitives, such as a high-performance on-chain decentralized exchange infrastructure, decentralized bridges, oracles, and a composable smart contract layer with CosmWasm. INJ is trading at $25.99, up by 1% in the last 24 hours.
